|
obsolete MATa1 (A1) pre-mRNA splicing
|
GO_0006377 |
[OBSOLETE. (Was not defined before being made obsolete).] |
|
obsolete mRNA polyadenylation
|
GO_0006378 |
[OBSOLETE. The enzymatic addition of a sequence of 40-200 adenylyl residues at the 3' end of a eukaryotic mRNA primary transcript.] |
|
obsolete mRNA cleavage
|
GO_0006379 |
[OBSOLETE. Any process in which a pre-mRNA or mRNA molecule is cleaved at specific sites or in a regulated manner.] |
|
positive regulation of natural killer cell mediated cytotoxicity
|
GO_0045954 |
[Any process that activates or increases the frequency, rate or extent of natural killer cell mediated cytotoxicity.] |
|
regulation of natural killer cell mediated cytotoxicity
|
GO_0042269 |
[Any process that modulates the frequency, rate, or extent of natural killer cell mediated cytotoxicity.] |
|
positive regulation of natural killer cell mediated immunity
|
GO_0002717 |
[Any process that activates or increases the frequency, rate, or extent of natural killer cell mediated immunity.] |
|
positive regulation of leukocyte mediated cytotoxicity
|
GO_0001912 |
[Any process that activates or increases the frequency, rate or extent of leukocyte mediated cytotoxicity.] |
|
negative regulation of calcium ion-dependent exocytosis
|
GO_0045955 |
[Any process that stops, prevents, or reduces the frequency, rate or extent of calcium ion-dependent exocytosis.] |
|
negative regulation of complement activation, alternative pathway
|
GO_0045957 |
[Any process that stops, prevents, or reduces the frequency, rate or extent of complement activation by the alternative pathway.] |
|
regulation of complement activation, alternative pathway
|
GO_0030451 |
[Any process that modulates the frequency, rate or extent of the alternative pathway of complement activation.] |
|
positive regulation of complement activation, alternative pathway
|
GO_0045958 |
[Any process that activates or increases the frequency, rate or extent of complement activation by the alternative pathway.] |
|
negative regulation of complement activation, classical pathway
|
GO_0045959 |
[Any process that stops, prevents, or reduces the frequency, rate or extent of complement activation by the classical pathway.] |
|
negative regulation of humoral immune response mediated by circulating immunoglobulin
|
GO_0002924 |
[Any process that stops, prevents, or reduces the frequency, rate, or extent of a humoral immune response mediated by circulating immunoglobulin.] |
|
negative regulation of mitotic recombination
|
GO_0045950 |
[Any process that inhibits or decreases the rate of DNA recombination during mitosis.] |
|
positive regulation of mitotic recombination
|
GO_0045951 |
[Any process that activates or increases the frequency, rate or extent of DNA recombination during mitosis.] |
|
regulation of juvenile hormone catabolic process
|
GO_0045952 |
[Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of juvenile hormone.] |
|
negative regulation of natural killer cell mediated cytotoxicity
|
GO_0045953 |
[Any process that stops, prevents, or reduces the rate of natural killer mediated cytotoxicity.] |
|
negative regulation of natural killer cell mediated immunity
|
GO_0002716 |
[Any process that stops, prevents, or reduces the frequency, rate, or extent of natural killer cell mediated immunity.] |
|
negative regulation of leukocyte mediated cytotoxicity
|
GO_0001911 |
[Any process that stops, prevents, or reduces the rate of leukocyte mediated cytotoxicity.] |
|
regulation of regulatory ncRNA processing
|
GO_0070920 |
[Any process that modulates the frequency, rate or extent of regulatory non-coding RNA processing.] |